What Whole Exome Sequencing (WES) Measures, and When to Choose It Over a Genome
A technical account of exome sequencing: capture chemistry, coverage statistics, and the failure modes that decide between WES and WGS.
A technical account of exome sequencing: capture chemistry, coverage statistics, and the failure modes that decide between WES and WGS.
A step-by-step guide to turning your own blood RNA-seq FASTQ files into a normalized expression matrix, cell-type estimates, and pathway scores you can track across timepoints.
What goes into a 510(k), De Novo, PMA or HDE submission to FDA, with format rules and review timeframes.
A breakdown of WGS pricing by depth, platform, and deliverable, from $200 research-core genomes to $5,000 clinical reports, plus the downstream storage and compute costs nobody quotes.
One fasting glucose of 100 sits at the edge of a threshold that was drawn by committee, and a single draw carries more measurement noise than most people expect. Here is how to read the number, what to measure next, and how to analyze the data yourself.
The national bodies that regulate drugs, devices, reimbursement, genetic resources and personal data in China, and what provinces handle.
A practical walkthrough for calling and filtering copy number variants from a 30x whole-genome CRAM, with the limits of what each caller can see.
A working pipeline that turns raw CNV calls from a personal genome into an annotated and prioritized table, with visual confirmation.
A working pipeline for human exome data with BWA-MEM, GATK HaplotypeCaller and VEP, with the flags that matter and the failure modes.
The public genome sites worth using, what each is good for, and how to go from a reference genome to a file that describes your own.
A technical walkthrough of pharmacogenetic star-allele calling from whole-genome data: which genes have real evidence, why CYP2D6 breaks most pipelines, and how to read a diplotype-to-phenotype report without over-trusting it.
Why fasting glucose is often the first value to drift upward, how to tell a real dawn rise from a sensor artifact, and how to analyze your own overnight CGM traces.
A technical answer to what biomarker testing at home can and cannot deliver: which analytes survive a mail-in kit, what dried blood spots and point-of-care sensors are good for, and how to build a longitudinal series you can analyze yourself.
A BUN of 5 mg/dL is almost always a reflection of protein intake, hydration, or liver urea synthesis rather than a problem in itself. Here is how to read it, what to pair it with, and when it deserves a clinician's attention.
A practical guide to the three things people mean by genome mapping, the aligners and flags we would use on a personal whole-genome dataset, and what the compute costs.
A working pipeline for taking raw whole-genome sequencing output (FASTQ, CRAM, VCF) through quality control, annotation, and variant triage, with the specific tools, flags, and thresholds we would use and the failure modes to watch for.
How Article 5(5) of the IVDR allows a health institution to make and use its own in vitro diagnostic, and the nine conditions attached.
A step-by-step guide to processing your own whole-genome and RNA sequencing data, and to validating the pipeline against a truth set.
A working guide to the TopHat/TopHat2 spliced alignment pipeline: when to use it, the exact commands, and the HISAT2 and salmon pipelines we would use for a personal transcriptome today.
A step-by-step guide to indexing a human reference, running bwa mem on 30x whole-genome FASTQs, and producing a sorted CRAM for variant calling.